Michael Ginsburg, MD (@mishaginsburg) 's Twitter Profile
Michael Ginsburg, MD

@mishaginsburg

Vascular & Interventional Radiologist. Patient Advocate & Outdoor Enthusiast. Only a life lived for others is a life worthwhile @AlbertEinstein

ID: 3988155677

linkhttps://providers.beaconhealthsystem.org/provider/Michael+Ginsburg/2485238 calendar_today18-10-2015 16:19:34

722 Tweet

1,1K Followers

1,1K Following

The Vigilant Fox 🦊 (@vigilantfox) 's Twitter Profile Photo

Argentina President Javier Milei Promotes Freedom at Davos 2024 (Full Speech) Yesterday, Milei said he wanted "to plant the ideas of freedom in a forum that is contaminated by the 2030 socialist agenda." Today, he did just that — and more: "The main leaders of the Western world

Tom Nash (@iamtomnash) 's Twitter Profile Photo

A must see interview of Alex Karp. This man makes most other CEOs look bad by just staying true to himself and not selling out. $PLTR

Beau Bosko Toskich, MD FSIR (@beautoskichmd) 's Twitter Profile Photo

#TACE+#Durvalumab+#Bevacizumab demonstrates superior PFS (23% reduced risk) when compared to #TACE alone for the treatment of #hepatocellularcarcinoma. Congratulations to the #Emerald1 investigators. Welcome the #combinationtherapy era.🧩 astrazeneca.com/media-centre/p…

Robert A Lookstein MD, MHCDL (@roblookstein) 's Twitter Profile Photo

Pub alert!! @mountsinaiIR Radioembolization plus Immune Checkpoint Inhibitor Therapy compared to Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma - Journal of Vascular and Interventional Radiology jvir.org/article/S1051-…

Palantir (@palantirtech) 's Twitter Profile Photo

“When we talk about AI removing jobs, at #Palantir, we think that AI enables people to do the jobs that they set out to do, and not the jobs that they have to do because the technology doesn’t exist.” ~ EVP Josh Harris, at #FIIPRIORITY Listen in: bit.ly/3OWitN6

“When we talk about AI removing jobs, at #Palantir, we think that AI enables people to do the jobs that they set out to do, and not the jobs that they have to do because the technology doesn’t exist.” ~ EVP Josh Harris, at #FIIPRIORITY

Listen in: bit.ly/3OWitN6
Society of Interventional Radiology (@sirspecialists) 's Twitter Profile Photo

A new study shows that one type of IGTA—microwave ablation (MWA)—appears to be a safe, effective and non-inferior option when compared to either resection or SBRT as a primary therapy for early NSCLC. #SIR24SLC brnw.ch/21wIb2t

Israel ישראל (@israel) 's Twitter Profile Photo

Jerusalem today: over 50,000 Muslim worshipers gathered for the third Friday Ramadan prayer. Wishing a Ramadan Kareem to all who are observing.

Konstantin Kisin (@konstantinkisin) 's Twitter Profile Photo

There are few things I enjoy quite as much as watching indoctrinated Western virtue signallers get epically destroyed by people from developing countries who are willing to be honest.

Northwestern Radiology (@nuradiology) 's Twitter Profile Photo

NM was asked by the Journal of Urology and Amer. Urol. Assn. to comment on #PAE in the management of Benign Prostatic Hyperplasia. This article was published to maximize awareness of this therapy for men with #BPH and lower urinary tract symptoms. bit.ly/3Vmoy7V #MensHealthWeek

NM was asked by the <a href="/JUrology/">Journal of Urology</a> and <a href="/AmerUrological/">Amer. Urol. Assn.</a> to comment on #PAE in the management of Benign Prostatic Hyperplasia. This article was published to maximize awareness of this therapy for men with #BPH and lower urinary tract symptoms. bit.ly/3Vmoy7V #MensHealthWeek
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Prognostic value of total tumor volume in CRC liver metastases Oncology Advance doi.org/10.1016/j.ejca… 🔎post-hoc of CAIRO5 👉Tumor total volume, but not RECIST 1.1 is prognostic for survival outcomes 👉5-yr Os 72% for TTV of 3 mL vs 7% for TTV of 300 mL ESMO - Eur. Oncology

Prognostic value of total tumor volume in CRC liver metastases
<a href="/OncologyAdvance/">Oncology Advance</a> 
doi.org/10.1016/j.ejca…
🔎post-hoc of CAIRO5
👉Tumor total volume, but not RECIST 1.1  is prognostic for survival outcomes 
👉5-yr Os  72% for TTV of 3 mL vs 7% for TTV of 300 mL
<a href="/myESMO/">ESMO - Eur. Oncology</a>
Osman Ahmed (@therealdoctoros) 's Twitter Profile Photo

Announcing the Global msk EMbolization regiStry (GEMS)! Excited to partner with Mark W. Little and Venkatesh (Kavi) Krishnasamy to launch the first ever global registry in #irad on GAE and other msk therapies 🦴. If interested in joining, please follow link below! 🔗📝 radiology.formstack.com/forms/gems_glo…

Announcing the Global msk EMbolization regiStry (GEMS)! Excited to partner with <a href="/marklittle_IR/">Mark W. Little</a> and <a href="/kavikrishVIR/">Venkatesh (Kavi) Krishnasamy</a> to launch the first ever global registry in #irad on GAE and other msk therapies 🦴.  If interested in joining, please follow link below! 🔗📝

radiology.formstack.com/forms/gems_glo…
W David Freeman, MD, FNCS, FAAN (@freemanwd) 's Twitter Profile Photo

Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis: The BASIS Randomized Clinical Trial in JAMA: 1.🧠 Purpose: The BASIS trial compared balloon angioplasty plus aggressive medical management versus aggressive medical management alone for symptomatic

Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis: The BASIS Randomized Clinical Trial in JAMA:

1.🧠 Purpose: The BASIS trial compared balloon angioplasty plus aggressive medical management versus aggressive medical management alone for symptomatic